Racké K, Reimann A, Schwörer H, Kilbinger H
Department of Pharmacology, J.W. Goethe-University, Frankfurt, Germany.
Behav Brain Res. 1996;73(1-2):83-7. doi: 10.1016/0166-4328(96)00075-7.
Large amounts of 5-HT are present in the mammalian intestine where the amine is concentrated in the enterochromaffin cells (ECs) of the mucosa. ECs have the enzymes to synthesize 5-HT, are endowed with a specific, imipramine-sensitive 5-HT uptake mechanism and can store 5-HT in specific secretory vesicles. ECs can secrete 5-HT in a calcium-dependent manner. In particular, calcium influx through voltage-regulated channels and receptor-mediated liberation of intracellular calcium can evoke 5-HT release. 5-HT secretion from ECs occurs predominantly at the interstitial side and is controlled by a complex pattern of receptor-mediated mechanisms. Stimulatory receptors (beta-adrenoceptors, muscarine, nicotine and 5-HT3 receptors) and inhibitory receptors (alpha 2-adrenoceptors, histamine H3, GABAA- and GABAB-, A2 and P2y alpha purine and 5-HT4 receptors as well as receptors for vasoactive intestinal polypeptide (VIP), pituitary adenylate cyclase stimulating peptide (PACAP) and somatostatin) have been shown to be involved in the control of 5-HT release from the ECs.
哺乳动物肠道中存在大量5-羟色胺(5-HT),该胺类物质集中于黏膜的肠嗜铬细胞(ECs)中。肠嗜铬细胞具有合成5-羟色胺的酶,具备一种特异性的、对丙咪嗪敏感的5-羟色胺摄取机制,并且能够将5-羟色胺储存于特定的分泌小泡中。肠嗜铬细胞能够以钙依赖的方式分泌5-羟色胺。具体而言,通过电压调节通道的钙内流以及受体介导的细胞内钙释放均可引发5-羟色胺的释放。肠嗜铬细胞分泌5-羟色胺主要发生在间质侧,并受受体介导机制的复杂模式调控。已证实,刺激性受体(β-肾上腺素能受体、毒蕈碱、烟碱和5-HT3受体)以及抑制性受体(α2-肾上腺素能受体、组胺H3、GABAA和GABAB、A2和P2yα嘌呤以及5-HT4受体,还有血管活性肠肽(VIP)、垂体腺苷酸环化酶激活肽(PACAP)和生长抑素的受体)参与了对肠嗜铬细胞释放5-羟色胺的控制。